examining the role of tissue-agnostic ctdna monitoring in breast cancer
Published 4 months ago • 100 plays • Length 2:08Download video MP4
Download video MP3
Similar videos
-
1:26
potential role of ctdna for early-stage breast cancer
-
1:36
ctdna assay for detection of recurrent disease in patients with early-stage breast cancer
-
3:15
the potential of circulating cell-free dna as a breast cancer biomarker
-
20:34
role of circulating tumor cells/dna & liquid biopsy in melanoma - david polsky
-
1:44
ctdna measurement via liquid biopsies in cancer of unknown primary
-
3:06
the application of liquid biopsy ctdna analysis in nsclc
-
22:36
cde series 9 - emerging role of genomic testing and liquid biopsy in breast cancer
-
56:59
circulating tumor cell analysis: delivering on the promise of liquid biopsy
-
7:24
clinical utility of circulating tumor cells and cell-free tumor dna in breast cancer
-
2:12
ctdna measurement via liquid biopsy: improving cancer detection and diagnosis
-
52:46
"circulating tumour dna: an increasingly powerful diagnostic tool for oncology" - nitzan rosenfeld
-
3:25
understand ctdna testing
-
13:28
what is ctdna? how is it helpful?
-
5:31
the evolving role of liquid biopsy
-
43:43
liquid biopsies to monitor cancer genomics | dr nitzan rosenfeld
-
6:58
liquid biopsy: introduction to ctdna
-
13:46
spotlight on testing: circulating cell free tumor dna and egfr t790m testing.
-
7:04
challenges in liquid biopsy
-
1:53
#putcancertothetest | what does ‘tumour-agnostic’ mean?